Comparison of Efficacy and Safety of Hydroxychloroquine and Teneligliptin in Type 2 Diabetes Patients who are Inadequately Controlled with Glimepiride, Metformin and Insulin therapy: A Randomized Controlled Trial with Parallel Group Design
Open Access
- 1 January 2017
- journal article
- Published by Heighten Science Publications Corporation
- Vol. 2 (1), 033-040
- https://doi.org/10.29328/journal.acem.1001009
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Efficacy and safety of hydroxychloroquine in the treatment of type 2 diabetes mellitus: a double blind, randomized comparison with pioglitazoneCurrent Medical Research and Opinion, 2014
- Teneligliptin: a DPP-4 inhibitor for the treatment of type 2 diabetesDiabetes, Metabolic Syndrome and Obesity, 2013
- Update on insulin therapy for type 2 diabetes.Journal of Clinical Endocrinology & Metabolism, 2012
- Prevalence of Diabetes among Men and Women in ChinaThe New England Journal of Medicine, 2010
- Adjust to Target in Type 2 DiabetesDiabetes Care, 2008
- Response to comments on: Nathan DM, Buse JB, Davidson MB et al. (2006) Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 49:1711–1721Diabetologia, 2006
- Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 DiabetesThe New England Journal of Medicine, 2005
- NIDDM in the elderlyDiabetes Care, 1996
- Frequency and Symptoms of Hypoglycaemia Experienced by Patients with Type 2 Diabetes Treated with InsulinDiabetic Medicine, 1993
- Hydroxychloroquine in Decompensated, Treatment-Refractory Noninsulin-Dependent Diabetes MellitusAnnals of Internal Medicine, 1990